AIGH Capital Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,520,359
Closed -$5.93M 50
2024
Q1
$5.93M Sell
1,520,359
-705,709
-32% -$2.69M 1.78% 17
2023
Q4
$9.62M Sell
2,226,068
-146,504
-6% -$495K 3.8% 8
2023
Q3
$7.35M Buy
+2,372,572
New +$7.84M 3.48% 11
2022
Q1
Sell
-497,639
Closed -$2.55M 51
2021
Q4
$2.55M Sell
497,639
-3,386
-0.7% -$16.6K 0.78% 30
2021
Q3
$2.12M Hold
501,025
0.44% 41
2021
Q2
$4.56M Hold
501,025
0.82% 26
2021
Q1
$4.82M Hold
501,025
1.01% 28
2020
Q4
$2.11M Buy
+501,025
New +$2.24M 0.86% 28

Other funds holding ALIM

AIGH Capital Management's ALIM Position: Q2 2024 in Review

AIGH Capital Management sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 1,520,359 shares — an estimated $5.93M sold.

AIGH Capital Management first reported a position in ALIM in Q4 2020 and held it in 8 quarters. The position peaked at $9.62M in Q4 2023. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • AIGH Capital Management reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • AIGH Capital Management sold 1,520,359 Alimera Sciences shares in Q2 2024, an estimated $5.93M.
  • AIGH Capital Management first reported a position in Alimera Sciences in Q4 2020 and held it in 8 quarters.
  • AIGH Capital Management's Alimera Sciences position peaked at $9.62M in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on AIGH Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.